Author:
Peregud-Pogorzelski J.,Lubinski J.,Brodkiewicz A.,Jakubowska A.,Debski R.,Wysocki M.
Publisher
Springer Berlin Heidelberg
Reference22 articles.
1. d’Auriol L, Macintyre E, Galibert F, Sigaux F (1989) In vitro amplification of T cell gene rearrangements: A new tool for the assessment of minimal residual disease in acute lymphocytic leukemias. Leukemia. 3: 155–158
2. Breit TM, Wolvers-Tettero ILM, Hahlen K, van Wering ER, van Dongen JJM (1991) Extensive junctional diversity of γδ T-cell receptors expressed by T-cell acute lymphoblastic leukemia: Implications for the detection of minimal residual disease. Leukemia 5: 1076–1086
3. Breit TM, Wolvers-Tettero ILM, Beishuizen A, Verhoeven MAJ, Wering ER, van Dongen JJM (1993) Southern blot patterns, frequencies, and junctional diversity of T-cell receptor -δ gene rearrangements in acute lymphoblastic leukemia. Blood 82: 3063–3074
4. Brisco M, Condon J, Sykes P, Neoh SH, Morley AA (1991) Detection and quantification of neoplastic cells in acute lymphoblastic leukemia by use of polymerase chain reaction. Br J Haematol 79: 211–217
5. Brisco M, Condon J, Highes E, Neoh S, Sykes P, Seshardi R, Toogood I, Waters K, Tauro G, Ekert H, & Morley A (1994) Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet. 343: 196–200